270 related articles for article (PubMed ID: 17408439)
1. Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters.
Najim RA; Sharquie KE; Abu-Raghif AR
J Dermatol; 2007 May; 34(5):308-14. PubMed ID: 17408439
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress: correlation with Behçet's disease duration, activity and severity.
Harzallah O; Kerkeni A; Baati T; Mahjoub S
Eur J Intern Med; 2008 Nov; 19(7):541-7. PubMed ID: 19013385
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte antioxidant activity and trace element levels in Behçet's disease.
Tüzün A; Aydin A; Turan M
Biol Trace Elem Res; 1998; 64(1-3):169-74. PubMed ID: 9845471
[TBL] [Abstract][Full Text] [Related]
6. Vitamin levels in Behçet's disease.
Kandi B; Cicek D; Ilhan N
J Dermatolog Treat; 2007; 18(2):69-75. PubMed ID: 17520462
[TBL] [Abstract][Full Text] [Related]
7. Oral zinc sulfate in the treatment of Behcet's disease: a double blind cross-over study.
Sharquie KE; Najim RA; Al-Dori WS; Al-Hayani RK
J Dermatol; 2006 Aug; 33(8):541-6. PubMed ID: 16923135
[TBL] [Abstract][Full Text] [Related]
8. Serum mannose-binding lectin levels are decreased in behcet's disease and associated with disease severity.
Inanc N; Mumcu G; Birtas E; Elbir Y; Yavuz S; Ergun T; Fresko I; Direskeneli H
J Rheumatol; 2005 Feb; 32(2):287-91. PubMed ID: 15693089
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of vitamins A, C, and E, beta-carotene, selenium, and zinc in patients with Behçet's disease: a controlled study.
Erel A; Ozsoy E; Biberoğlu G; Bilgihan A; Hasanoğlu A; Yis MO; Atahan C; Oruk S
Biol Trace Elem Res; 2003 Nov; 95(2):97-106. PubMed ID: 14645991
[TBL] [Abstract][Full Text] [Related]
11. Urokinase plasminogen activator receptor levels in Behcet's disease.
Birengel S; Yalçındağ FN; Yalçındağ A; Sahli E; Batıoğlu F
Thromb Res; 2011 Sep; 128(3):274-6. PubMed ID: 21470667
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of allantoin levels as a new marker of oxidative stress in Behçet's disease.
Yardim-Akaydin S; Sepici A; Ozkan Y; Simşek B; Sepici V
Scand J Rheumatol; 2006; 35(1):61-4. PubMed ID: 16467045
[TBL] [Abstract][Full Text] [Related]
13. Behçet's disease and hearing loss.
AK E; Harputluoglu U; Oghan F; Baykal B
Auris Nasus Larynx; 2004 Mar; 31(1):29-33. PubMed ID: 15041051
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
[TBL] [Abstract][Full Text] [Related]
15. Serum interleukin-8 as a serologic marker of activity in Behçet's disease.
Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N
Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867
[TBL] [Abstract][Full Text] [Related]
16. Serum zinc, copper and magnesium in Behçet's disease.
Cengiz K; Gürkaynak F
Mater Med Pol; 1988; 20(3):190-3. PubMed ID: 3244293
[No Abstract] [Full Text] [Related]
17. High levels of oxidative stress in patients with advanced lung cancer.
Esme H; Cemek M; Sezer M; Saglam H; Demir A; Melek H; Unlu M
Respirology; 2008 Jan; 13(1):112-6. PubMed ID: 18197920
[TBL] [Abstract][Full Text] [Related]
18. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
[TBL] [Abstract][Full Text] [Related]
19. Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course.
Choi CH; Kim TI; Kim BC; Shin SJ; Lee SK; Kim WH; Kim HS
Dis Colon Rectum; 2006 Dec; 49(12):1849-59. PubMed ID: 17080284
[TBL] [Abstract][Full Text] [Related]
20. Trace elements and oxidative stress in chronic obstructive pulmonary disease.
Isik B; Isik RS; Ceylan A; Calik O
Saudi Med J; 2005 Dec; 26(12):1882-5. PubMed ID: 16380766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
